# Lesional Evaluation of High Risk Patients With Neoatherosclerosis Treated With Rosuvastatin and Eicosapentaenoic Acid Using Optical Coherence Tomography(OCT)[LINK IT TWO]

> **NCT03657758** · PHASE4 · UNKNOWN · sponsor: **Kobe University** · enrollment: 75 (estimated)

## Conditions studied

- Coronary Artery Disease
- Angina Pectoris

## Interventions

- **DRUG:** EPA and rosuvastatin
- **DRUG:** High dose rosuvastatin

## Key facts

- **NCT ID:** NCT03657758
- **Lead sponsor:** Kobe University
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-09-17
- **Primary completion:** 2020-08-31
- **Final completion:** 2021-08-31
- **Target enrollment:** 75 (ESTIMATED)
- **Last updated:** 2018-09-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03657758

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03657758, "Lesional Evaluation of High Risk Patients With Neoatherosclerosis Treated With Rosuvastatin and Eicosapentaenoic Acid Using Optical Coherence Tomography(OCT)[LINK IT TWO]". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT03657758. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*